SITC 2015 Annual Meeting & Associated Programs: 2015 Biomarkers Debate - Biomarkers in Cancer Immunotherapy: Oasis or Mirage November 8, 2015 Gaylord National Hotel & Convention Center National Harbor, MDProgram OrganizersOrganized in collaboration with the SITC Annual Program Committee and the SITC Industry CommitteeProgram SummaryFrom the Society for Immunotherapy of Cancer (SITC), these enduring materials from the 2015 Biomarkers Debate organized in collaboration with the SITC Annual Program Committee and the SITC Industry Committee and presented on Sunday, November 8, 2015 in National Harbor, MD, consist of a point-counterpoint debate surrounding the utility of biomarkers in cancer immunotherapy, complete with audience Question & Answer and extended panel discussion about the future of biomarkers and clinical development. The use of biomarkers to select patients for treatment is becoming increasingly important in cancer treatment, especially as they relate to cancer immunotherapy. However, the biology surrounding biomarkers for cancer immunotherapy is complex, and it is often difficult to take data from clinical outcomes and translate them into practice. Along with multiple PD-L1 diagnostic assays with differing results, these points of contention have led to dilemmas and confusion within the cancer immunotherapy field. #Biomarkers #ClinicalTrials #Melanoma #Non-SmallCellLungCancer #RenalCellCarcinoma #PresentationSlides #AnnualMeeting #SITC #Cytokines #Nivolumab #Pembrolizumab #Atezolizumab #Clinician #Industry #Oncologist#Researcher #2015 #Video
Meeting: 2015 Biomarkers Debate; Presentation: Biomarkers Panel Discussion; Date: November 8, 201500:38:46
Meeting: 2015 Biomarkers Debate; Presentation: Science of Biomarkers; Presenter: Daniel S. Chen, MD, PhD – Genentech; Date: November 8, 201500:23:58
Meeting: 2015 Biomarkers Debate; Presentation: Biomarkers for Cancer Immunotherapy- Con; Presenter: Steven Averbuch, MD – Bristol-Myers Squibb; Date: November 8, 201500:22:02
Meeting: 2015 Biomarkers Debate; Presentation: Biomarkers for Cancer Immunotherapy Debate; Presenter: Steven Averbuch, MD – Bristol-Myers Squibb and Daniel S. Chen, MD, PhD – Genentech; Date: November 8, 201500:17:43
Meeting: 2015 Biomarkers Debate; Presentation: Other Topics in Biomarkers Discussion- Blood-Based; Presenter: Michael D. Kalos, PhD – Eli Lilly and Company; Date: November 8, 201500:12:58
Meeting: 2015 Biomarkers Debate; Presentation: Future Biomarkers - Other Biomarkers; Presenter: Naiyer Rizvi, MD – Columbia University Medical Center; Date: November 8, 201500:09:16
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us